| scholarly article | Q13442814 |
| P2093 | author name string | Desjeux JF | |
| Heyman M | |||
| Mahraoui L | |||
| Droy-Lefaix MT | |||
| Plique O | |||
| P2860 | cites work | Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor | Q28289854 |
| IFN-gamma modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding | Q30467607 | ||
| 5'-adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers | Q33900552 | ||
| A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion | Q34192675 | ||
| Significance of intestinal food protein transport | Q35391145 | ||
| Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors | Q35856199 | ||
| Cytokine expression in chronic inflammatory disease | Q40409049 | ||
| Pathophysiologic alterations induced by tumor necrosis factor. | Q40890038 | ||
| Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate | Q41419600 | ||
| Mononuclear cells from infants allergic to cow's milk secrete tumor necrosis factor alpha, altering intestinal function. | Q41462878 | ||
| Activated eosinophils evoke chloride secretion in model intestinal epithelia primarily via regulated release of 5'-AMP. | Q41514059 | ||
| Analysis of enteropathy induced by tumour necrosis factor alpha. | Q41579874 | ||
| Tumour Necrosis factor-α induces morphological and functional alterations of intestinal HT29 cl.19A cell monolayers | Q42479137 | ||
| Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma | Q42508124 | ||
| Effect of diosmectite on intestinal permeability changes in acute diarrhea: a double-blind placebo-controlled trial | Q43486285 | ||
| Control study of oral rehydration solution (ORS)/ORS + dioctahedral smectite in hospitalized Thai infants with acute secretory diarrhea | Q43877043 | ||
| Changes in gastro-intestinal motility induced by cholera toxin and experimental osmotic diarrhoea in dogs: effects of treatment with an argillaceous compound | Q45247271 | ||
| Protective action of diosmectite treatment on digestive disturbances induced by intestinal anaphylaxis in the guinea-pig | Q46139781 | ||
| Smectite in acute diarrhea in children: a double-blind placebo-controlled clinical trial | Q46959523 | ||
| Control randomized study of rehydration/rehydration with dioctahedral smectite in ambulatory Thai infants with acute diarrhea. | Q50151213 | ||
| Tumor necrosis factor depresses gut absorptive function. | Q51667197 | ||
| Pepsin hydrolysis of the adherent mucus barrier and subsequent gastric mucosal damage in the rat: effect of diosmectite and 16,16 dimethyl prostaglandin E2. | Q52507641 | ||
| Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). | Q54005785 | ||
| Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines. | Q54406297 | ||
| A new suspension form of smectite (Liquid 'Diasorb') for the treatment of acute diarrhoea: a randomized comparative study | Q67940703 | ||
| Action of T-2 toxin on gastrointestinal transit in mice: protective effect of an argillaceous compound | Q69044466 | ||
| Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor | Q70128457 | ||
| Cytotoxicity of tumor necrosis factor for thyroid epithelial cells and its regulation by interferon-gamma | Q70370051 | ||
| Synergistic effects of recombinant tumour necrosis factor and interferon-gamma on rat thyroid cell growth and Ia antigen expression | Q70381567 | ||
| Horseradish peroxidase transport across adult rabbit jejunum in vitro | Q70389164 | ||
| A histological, enzymatic and water-electrolyte study of the action of smectite, a mucoprotective clay, on experimental infectious diarrhoea in the rabbit | Q71469529 | ||
| Ultrastructural changes in the upper small intestinal mucosa in patients with cholera | Q71890490 | ||
| Tumour-necrosis-factor antibody treatment in Crohn's disease | Q72225713 | ||
| New paradigms for the pathophysiology of infectious diarrhea | Q72463150 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | TNF | Q18032037 |
| P304 | page(s) | 339-343 | |
| P577 | publication date | 1997-03-01 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | Apical effect of diosmectite on damage to the intestinal barrier induced by basal tumour necrosis factor-alpha | |
| P478 | volume | 40 |
| Q36904890 | Acute infectious pediatric gastroenteritis: beyond oral rehydration therapy |
| Q38040321 | Agents that act luminally to treat diarrhoea and constipation |
| Q54778223 | Alteration of intestinal intraepithelial lymphocytes after massive small bowel resection |
| Q37419350 | Anti-diarrheal effects of diosmectite in the treatment of acute diarrhea in children: a review |
| Q35046279 | Anti-inflammatory effect of diosmectite in hapten-induced colitis in the rat. |
| Q94502377 | Chapter 11.6 Clays and Clay Minerals as Drugs |
| Q39027909 | Efficacy and safety of diosmectite in acute childhood diarrhoea: a meta-analysis |
| Q35094295 | Efficacy of diosmectite (smecta) in the treatment of acute watery diarrhoea in adults: a multicentre, randomized, double-blind, placebo-controlled, parallel group study. |
| Q33465649 | Efficacy of the Natural Clay, Calcium Aluminosilicate Anti-Diarrheal, in Reducing Medullary Thyroid Cancer-Related Diarrhea and Its Effects on Quality of Life: A Pilot Study |
| Q34266228 | Guidelines for adults on self-medication for the treatment of acute diarrhoea |
| Q35207643 | Intestinal epithelial barrier dysfunction in food hypersensitivity |
| Q36578138 | Lactobacillus GG (LGG) and smectite versus LGG alone for acute gastroenteritis: a double-blind, randomized controlled trial |
| Q92184716 | Measurement of novel intestinal secretory and barrier pathways and effects of proteases |
| Q33230890 | Meta-analysis: Smectite in the treatment of acute infectious diarrhoea in children. |
| Q46836150 | Mitigation of colitis with NovaSil clay therapy. |
| Q44934665 | PAR2 activation alters colonic paracellular permeability in mice via IFN-gamma-dependent and -independent pathways |
| Q89450267 | Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults |
| Q43223298 | Role of antidiarrhoeal drugs as adjunctive therapies for acute diarrhoea in children. |
| Q35351969 | Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease |
| Q37578593 | The Role of Mast Cells in Irritable Bowel Syndrome |
| Q37858649 | The clinical significances of irritable bowel syndrome in Taiwan |
| Q40820507 | The role of protein kinase C isozymes in TNF-alpha-induced cytotoxicity to a rat intestinal epithelial cell line |
Search more.